Clinical Scorecard: Incidence of Urinary Tract Infections Among Individuals with Kidney Stones: A Matched Cohort Analysis Over 19 Years of Follow-Up
At a Glance
Category
Detail
Condition
Kidney Stone Disease (KSD) and Urinary Tract Infections (UTIs)
Key Mechanisms
Urease-producing bacteria contribute to struvite stone formation; bacteria presence also noted in calcium oxalate and phosphate stones though causality is unclear
Target Population
Patients with kidney stone disease presenting to a tertiary referral hospital metabolic assessment clinic
Care Setting
Tertiary referral hospital and general practice settings within Hampshire and surrounding regions
Key Highlights
Patients with KSD have a significantly increased risk of developing UTIs compared to matched controls (HR ~5.7).
Struvite stones (4% of stones) are linked to urease-producing bacterial infections; calcium oxalate and phosphate stones also show bacterial DNA but causal link is unclear.
Long-term follow-up (median 19 years) shows 18.7% of stone formers developed UTIs versus 14.1% in comparators.
Guideline-Based Recommendations
Diagnosis
UTI diagnosis based on symptomatic presentation recorded in general practice records; exact diagnostic criteria (symptoms, dipstick, culture) unclear.
Diabetes mellitus diagnosis per NICE/WHO guidelines (HbA1c >48 mmol/mol or random glucose >11 mmol/L).
Management
Routine metabolic assessment and follow-up for stone formers to monitor for UTI development.
Consideration of stone composition in risk stratification for UTI.
Monitoring & Follow-up
Long-term monitoring of stone formers for UTI occurrence using electronic health records.
Surveillance for stone recurrence especially in patients with prior UTI episodes.
Risks
Increased risk of UTI in KSD patients independent of diabetes status.
Potential for urosepsis in a minority of patients with KSD.
Patient & Prescribing Data
819 patients with kidney stone disease and 2477 matched stone-free comparators
Stone formers have a higher incidence of UTIs over long-term follow-up; management should consider infection risk especially in calcium oxalate stone formers.
Clinical Best Practices
Use matched cohort data to inform risk assessment for UTIs in patients with kidney stones.
Incorporate stone composition analysis to guide clinical monitoring and preventive strategies.
Adjust for comorbidities such as diabetes when evaluating UTI risk in stone formers.
Utilize integrated electronic health records for comprehensive longitudinal patient follow-up.
With its combination of UWF imaging, OCT integration, and intelligent review tools, the MonacoPro represents the next step in comprehensive retinal evaluation. By improving image quality, enhancing diagnostic confidence, and streamlining workflow, the system supports clinicians in delivering more efficient, informed, and patient-centered care.
